As of January 22, 2025, Phreesia (PHR) has a market cap of $1.58 billion USD. According to our data, Phreesia is ranked No.4519 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.58 B |
8.19%
|
Dec 31, 2024 | $1.46 B |
8.68%
|
Dec 29, 2023 | $1.35 B |
-28.46%
|
Dec 30, 2022 | $1.88 B |
-22.32%
|
Dec 31, 2021 | $2.42 B |
-23.22%
|
Dec 31, 2020 | $3.15 B |
103.68%
|
Dec 31, 2019 | $1.55 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Allscripts
MDRX
|
$0.92 B |
0.000 M
|
USA
|
McKesson
MCK
|
$74.16 B |
0.002 M
|
USA
|
Teladoc Health
TDOC
|
$1.70 B |
-0.000 M
|
USA
|
Veeva Systems
VEEV
|
$37.19 B |
0.002 M
|
USA
|
Health Catalyst
HCAT
|
$0.34 B |
0.000 M
|
USA
|
Omnicell
OMCL
|
$1.97 B |
0.000 M
|
USA
|
Premier
PINC
|
$2.12 B |
0.000 M
|
USA
|
Evolent Health
EVH
|
$1.15 B |
-0.000 M
|
USA
|
Market Cap | = | PHR Stock Price | * | PHR Shares Outstanding |
= | $27.22 | * | 58.12 M | |
= | $1.58 B |